Global publication productivity in dermatology: a bibliometric description of the past and estimation of the future.
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
07
10
2020
accepted:
11
02
2021
pubmed:
4
3
2021
medline:
22
6
2021
entrez:
3
3
2021
Statut:
ppublish
Résumé
In the past two centuries, generations of dermatologists around the world have created an enormous number of publications. To our knowledge, no bibliometric analysis of these publications has been performed so far, nor have registered trials been analysed to anticipate future publication trends. To determine the global distribution of national publication productivity, most published topics, institutions and funding sources contributing most to publications and to anticipate future trends based on registered clinical trials. Following pre-assessment on PubMed, Embase, Web of Science and Scopus, the number of publications for 'dermatology' was determined for each of 195 countries, normalized per 1 Mio inhabitants and bibliometrically analysed. Dermatology-related trials registered at clinicaltrials.gov were specified by the top-10 diagnoses for the top-10 countries. The search yielded 1 071 518 publications between 1832 and 2019 with the top-5 diagnoses being melanoma, basal cell carcinoma, psoriasis, pruritus/itch and atopic dermatitis. The top-3 countries with highest absolute numbers of publications were the USA (30.6%), Germany (8.1%) and the UK (8.1%), whereas Switzerland, Denmark and Sweden had the highest publication rates when normalized by inhabitants. The most productive affiliation was the Harvard Medical School, the leading funding source the National Institutes of Health. Currently, maximum number of trials are registered in the USA (8111), France (1543) and Canada (1368). The highest percentage of all dermatology-related trials in a specific country were as follows: Melanoma in the Netherlands (24.8%), psoriasis in Germany (21.7%) and atopic dermatitis in Japan (15.9%). The top-10 countries including the USA, Canada, a few European and Asian countries contributed more than 3/4 of all publications. The USA hold the dominant leader position both in past publication productivity and currently registered trials. While most Western countries continue to focus their research on the top-10 topics, China and India appear to prioritize their scope towards other topics.
Sections du résumé
BACKGROUND
BACKGROUND
In the past two centuries, generations of dermatologists around the world have created an enormous number of publications. To our knowledge, no bibliometric analysis of these publications has been performed so far, nor have registered trials been analysed to anticipate future publication trends.
OBJECTIVES
OBJECTIVE
To determine the global distribution of national publication productivity, most published topics, institutions and funding sources contributing most to publications and to anticipate future trends based on registered clinical trials.
METHODS
METHODS
Following pre-assessment on PubMed, Embase, Web of Science and Scopus, the number of publications for 'dermatology' was determined for each of 195 countries, normalized per 1 Mio inhabitants and bibliometrically analysed. Dermatology-related trials registered at clinicaltrials.gov were specified by the top-10 diagnoses for the top-10 countries.
RESULTS
RESULTS
The search yielded 1 071 518 publications between 1832 and 2019 with the top-5 diagnoses being melanoma, basal cell carcinoma, psoriasis, pruritus/itch and atopic dermatitis. The top-3 countries with highest absolute numbers of publications were the USA (30.6%), Germany (8.1%) and the UK (8.1%), whereas Switzerland, Denmark and Sweden had the highest publication rates when normalized by inhabitants. The most productive affiliation was the Harvard Medical School, the leading funding source the National Institutes of Health. Currently, maximum number of trials are registered in the USA (8111), France (1543) and Canada (1368). The highest percentage of all dermatology-related trials in a specific country were as follows: Melanoma in the Netherlands (24.8%), psoriasis in Germany (21.7%) and atopic dermatitis in Japan (15.9%).
CONCLUSION
CONCLUSIONS
The top-10 countries including the USA, Canada, a few European and Asian countries contributed more than 3/4 of all publications. The USA hold the dominant leader position both in past publication productivity and currently registered trials. While most Western countries continue to focus their research on the top-10 topics, China and India appear to prioritize their scope towards other topics.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1424-1433Informations de copyright
© 2021 European Academy of Dermatology and Venereology.
Références
Hollestein LM, Nijsten T. An insight into the global burden of skin diseases. J Invest Dermatol 2014; 134: 1499-1501.
Kulkarni AV, Aziz B, Shams I, Busse JW. Comparisons of citations in Web of Science, Scopus, and Google Scholar for articles published in general medical journals. JAMA 2009; 302: 1092-1096.
Patel VM, Ashrafian H, Almoudaris A et al. Measuring academic performance for healthcare researchers with the H index: which search tool should be used? Med Princ Pract 2013; 22: 178-183.
Man JP, Weinkauf JG, Tsang M, Sin DD. Why do some countries publish more than others? An international comparison of research funding, English proficiency and publication output in highly ranked general medical journals. Eur J Epidemiol 2004; 19: 811-817.
Choudhri AF, Siddiqui A, Khan NR, Cohen HL. Understanding bibliometric parameters and analysis. Radiographics 2015; 35: 736-746.
JAMA Evidence-based medicine. A new approach to teaching the practice of medicine. 1992; 268: 2420-2425.
Szajewska H. Evidence-based medicine and clinical research: both are needed, neither is perfect. Ann Nutr Metab 2018; 72(Suppl 3): 13-23.
Asnake M. The importance of scientific publication in the development of public health. Cien Saude Colet 2015; 20: 1972-1973.
Chapman D. Health-related databases. J Can Acad Child Adolesc Psychiatry 2009; 18: 148-149.
Matthews NH, Li WQ, Qureshi AA, Weinstock MA, Cho E. Epidemiology of melanoma. In Ward WH JM Farma, eds. Cutaneous Melanoma: Etiology and Therapy, Codon Publications, Brisbane, AU, 2017.
Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ 2020; 369: m1590.
Murray CJL, Lopez AD, World Health O. Global Comparative Assessments in the Health Sector: Disease Burden, Expenditures and Intervention Packages, World Health Organization, Geneva, 1994.
World Health Organization. Global status report on noncommunicable diseases, 2010, 2011. https://www.who.int/nmh/publications/ncd_report2010/en/ (last accessed 15 August 2020).
Man H, Xin S, Bi W et al. Comparison of publication trends in dermatology among Japan, South Korea and Mainland China. BMC Dermatol 2014; 14: 1.
Belinchón I, Ramos JM, Sánchez-Yus E, Betlloch I. Dermatological scientific production from European Union authors (1987-2000). Scientometrics 2004; 61: 271-281.
Xin S, Mauro JA, Mauro TM, Elias PM, Man MQ. Ten-year publication trends in dermatology in mainland China. Int J Dermatol 2014; 53: e438-e442.
Unesco Institute for Statistics. How much does your country invest in r&d? 2020. URL http://uis.unesco.org/apps/visualisations/research-and-development-spending/ (last accessed August 7 2020).
Moses H, 3rd, Matheson DH, Cairns-Smith S, George BP, Palisch C, Dorsey ER. The anatomy of medical research: US and international comparisons. JAMA 2015; 313: 174-189.
Tasli L, Kacar N, Aydemir EH. Scientific productivity of OECD countries in dermatology journals within the last 10-year period. Int J Dermatol 2012; 51: 665-671.
Bray JK, Feldman SR. Analyzing China's contributions to major dermatologic journals from the past 20 years. Dermatol Online J 2020; 26.13030/qt8f54k6bp
Bornmann L, Wagner C, Leydesdorff L. The geography of references in elite articles: which countries contribute to the archives of knowledge? PLoS One 2018; 13.e0194805
Hay RJ, Augustin M, Griffiths CEM, Sterry W. The global challenge for skin health. Br J Dermatol 2015; 172: 1469-1472.
Viergever RF. The mismatch between the health research and development (R&D) that is needed and the R&D that is undertaken: an overview of the problem, the causes, and solutions. Glob Health Action 2013; 6: 22450.